

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.83139505 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.53538503 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.53538503 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.49210374 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88775962 |
| 6 | central nervous system myelination (GO:0022010) | 4.67238334 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 4.67238334 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.44937972 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.39497853 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.34384471 |
| 11 | cellular extravasation (GO:0045123) | 4.29140899 |
| 12 | histone H3-K36 demethylation (GO:0070544) | 4.24176963 |
| 13 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.12483335 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.10817328 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02458582 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.00185133 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.97710155 |
| 18 | microglial cell activation (GO:0001774) | 3.94695096 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.93193813 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 3.92940746 |
| 21 | intracellular lipid transport (GO:0032365) | 3.90462350 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.88454721 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88369106 |
| 24 | detection of other organism (GO:0098543) | 3.85609185 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81661153 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76705677 |
| 27 | nerve growth factor signaling pathway (GO:0038180) | 3.70688174 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.67805569 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.65501225 |
| 30 | nucleoside diphosphate catabolic process (GO:0009134) | 3.60617969 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.59334070 |
| 32 | ensheathment of neurons (GO:0007272) | 3.58405302 |
| 33 | axon ensheathment (GO:0008366) | 3.58405302 |
| 34 | myelination (GO:0042552) | 3.56085068 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.54684450 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.52576949 |
| 37 | L-amino acid import (GO:0043092) | 3.52015339 |
| 38 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.46609771 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43051098 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.38870774 |
| 41 | response to interleukin-15 (GO:0070672) | 3.37034260 |
| 42 | negative T cell selection (GO:0043383) | 3.36884406 |
| 43 | regulation of heat generation (GO:0031650) | 3.34679003 |
| 44 | regulation of mast cell activation (GO:0033003) | 3.34386067 |
| 45 | macrophage activation (GO:0042116) | 3.34021957 |
| 46 | response to peptidoglycan (GO:0032494) | 3.33564056 |
| 47 | detection of bacterium (GO:0016045) | 3.31886902 |
| 48 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.27649517 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.27435353 |
| 50 | hepatocyte apoptotic process (GO:0097284) | 3.25523330 |
| 51 | neutrophil activation (GO:0042119) | 3.24955550 |
| 52 | response to host immune response (GO:0052572) | 3.20860875 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20860875 |
| 54 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.18145573 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 3.15677319 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 3.11423217 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.10732527 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.10598485 |
| 59 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08140168 |
| 60 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.07214385 |
| 61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.05518448 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05412341 |
| 63 | cortical actin cytoskeleton organization (GO:0030866) | 3.03796080 |
| 64 | positive thymic T cell selection (GO:0045059) | 3.03731791 |
| 65 | positive T cell selection (GO:0043368) | 3.03728417 |
| 66 | nucleus localization (GO:0051647) | 3.00910371 |
| 67 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.98705139 |
| 68 | protein targeting to lysosome (GO:0006622) | 2.97546425 |
| 69 | establishment of protein localization to vacuole (GO:0072666) | 2.97546425 |
| 70 | protein targeting to vacuole (GO:0006623) | 2.97546425 |
| 71 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.97174568 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97120262 |
| 73 | T-helper 1 type immune response (GO:0042088) | 2.96233000 |
| 74 | respiratory burst (GO:0045730) | 2.96162675 |
| 75 | interferon-gamma production (GO:0032609) | 2.94943534 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.94737487 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.94213564 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91089988 |
| 79 | cellular response to interleukin-15 (GO:0071350) | 2.90720358 |
| 80 | dendritic cell migration (GO:0036336) | 2.89284119 |
| 81 | negative regulation of adaptive immune response (GO:0002820) | 2.88168566 |
| 82 | myelin maintenance (GO:0043217) | 2.87200987 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86448738 |
| 84 | response to host (GO:0075136) | 2.86448738 |
| 85 | response to host defenses (GO:0052200) | 2.86448738 |
| 86 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.84957173 |
| 87 | immunoglobulin mediated immune response (GO:0016064) | 2.84704755 |
| 88 | * protein localization to endosome (GO:0036010) | 2.82904862 |
| 89 | cellular response to ethanol (GO:0071361) | 2.81758341 |
| 90 | mast cell activation (GO:0045576) | 2.80752729 |
| 91 | leukocyte aggregation (GO:0070486) | 2.80514698 |
| 92 | granulocyte activation (GO:0036230) | 2.80210666 |
| 93 | leukocyte degranulation (GO:0043299) | 2.79341752 |
| 94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.78855076 |
| 95 | ether lipid metabolic process (GO:0046485) | 2.78280979 |
| 96 | negative regulation of neurotransmitter transport (GO:0051589) | 2.77004611 |
| 97 | hypotonic response (GO:0006971) | 2.76046099 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75360789 |
| 99 | synaptic vesicle maturation (GO:0016188) | 2.75270533 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74909476 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74044353 |
| 102 | cortical cytoskeleton organization (GO:0030865) | 2.72648209 |
| 103 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.71612682 |
| 104 | negative regulation of B cell mediated immunity (GO:0002713) | 2.71612682 |
| 105 | I-kappaB phosphorylation (GO:0007252) | 2.70463625 |
| 106 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.68970534 |
| 107 | locomotory exploration behavior (GO:0035641) | 2.68969081 |
| 108 | response to lipoprotein particle (GO:0055094) | 2.68806696 |
| 109 | T cell selection (GO:0045058) | 2.65827229 |
| 110 | positive regulation of interferon-alpha production (GO:0032727) | 2.63717425 |
| 111 | import into cell (GO:0098657) | 2.63184076 |
| 112 | amino acid import (GO:0043090) | 2.59500704 |
| 113 | virion attachment to host cell (GO:0019062) | 2.59167887 |
| 114 | adhesion of symbiont to host cell (GO:0044650) | 2.59167887 |
| 115 | Golgi to endosome transport (GO:0006895) | 2.59047713 |
| 116 | asymmetric protein localization (GO:0008105) | 2.58937890 |
| 117 | cellular potassium ion homeostasis (GO:0030007) | 2.58203143 |
| 118 | regulation of ARF protein signal transduction (GO:0032012) | 2.55716725 |
| 119 | dendrite morphogenesis (GO:0048813) | 2.52286513 |
| 120 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.51015025 |
| 121 | regulation of Rap GTPase activity (GO:0032317) | 2.47076467 |
| 122 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.45201833 |
| 123 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.45046015 |
| 124 | stress fiber assembly (GO:0043149) | 2.43088438 |
| 125 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.40357919 |
| 126 | apical protein localization (GO:0045176) | 2.35925090 |
| 127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34638908 |
| 128 | astrocyte development (GO:0014002) | 2.33310247 |
| 129 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.33193780 |
| 130 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.32897515 |
| 131 | potassium ion import (GO:0010107) | 2.30927075 |
| 132 | clathrin coat assembly (GO:0048268) | 2.29435640 |
| 133 | presynaptic membrane organization (GO:0097090) | 2.28242696 |
| 134 | establishment of nucleus localization (GO:0040023) | 2.27906235 |
| 135 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.27379988 |
| 136 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.27309305 |
| 137 | sodium ion export (GO:0071436) | 2.24586225 |
| 138 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.23988154 |
| 139 | myelination in peripheral nervous system (GO:0022011) | 2.23322513 |
| 140 | peripheral nervous system axon ensheathment (GO:0032292) | 2.23322513 |
| 141 | vesicle transport along microtubule (GO:0047496) | 2.22575172 |
| 142 | adenosine receptor signaling pathway (GO:0001973) | 2.20895812 |
| 143 | fatty acid elongation (GO:0030497) | 2.20885314 |
| 144 | dendritic spine morphogenesis (GO:0060997) | 2.19544508 |
| 145 | * regulation of ARF GTPase activity (GO:0032312) | 2.19293214 |
| 146 | membrane raft organization (GO:0031579) | 2.15415475 |
| 147 | oligodendrocyte differentiation (GO:0048709) | 2.14843861 |
| 148 | glutamate receptor signaling pathway (GO:0007215) | 2.14324404 |
| 149 | regulation of dendritic spine development (GO:0060998) | 2.13640803 |
| 150 | negative regulation of protein localization to cell surface (GO:2000009) | 2.12098671 |
| 151 | * cellular response to nerve growth factor stimulus (GO:1990090) | 2.10870336 |
| 152 | * response to nerve growth factor (GO:1990089) | 2.10870336 |
| 153 | phospholipid translocation (GO:0045332) | 2.10330247 |
| 154 | lipid translocation (GO:0034204) | 2.10330247 |
| 155 | Rap protein signal transduction (GO:0032486) | 2.10326642 |
| 156 | transmission of nerve impulse (GO:0019226) | 2.09289145 |
| 157 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.08839630 |
| 158 | neuronal action potential propagation (GO:0019227) | 2.08760716 |
| 159 | neuromuscular process controlling balance (GO:0050885) | 2.08358858 |
| 160 | dendritic spine organization (GO:0097061) | 2.06374727 |
| 161 | adult walking behavior (GO:0007628) | 2.06371662 |
| 162 | establishment of protein localization to Golgi (GO:0072600) | 2.06351554 |
| 163 | positive regulation of macrophage cytokine production (GO:0060907) | 2.05040535 |
| 164 | negative regulation of axonogenesis (GO:0050771) | 2.04789468 |
| 165 | protein targeting to Golgi (GO:0000042) | 2.03247463 |
| 166 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.03195442 |
| 167 | presynaptic membrane assembly (GO:0097105) | 2.02680892 |
| 168 | heterotypic cell-cell adhesion (GO:0034113) | 2.01964575 |
| 169 | positive regulation by symbiont of host defense response (GO:0052509) | 2.00382592 |
| 170 | modulation by symbiont of host defense response (GO:0052031) | 2.00382592 |
| 171 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.00382592 |
| 172 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.00382592 |
| 173 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.00382592 |
| 174 | modulation by symbiont of host immune response (GO:0052553) | 2.00382592 |
| 175 | negative regulation of exocytosis (GO:0045920) | 2.00240269 |
| 176 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 1.99853893 |
| 177 | Rac protein signal transduction (GO:0016601) | 1.99171116 |
| 178 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.99141537 |
| 179 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.98730692 |
| 180 | semaphorin-plexin signaling pathway (GO:0071526) | 1.98095535 |
| 181 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 1.97036864 |
| 182 | glycosylceramide metabolic process (GO:0006677) | 1.96976694 |
| 183 | L-serine transport (GO:0015825) | 1.96817338 |
| 184 | adhesion of symbiont to host (GO:0044406) | 1.92727354 |
| 185 | neuronal ion channel clustering (GO:0045161) | 1.92098670 |
| 186 | glycine transport (GO:0015816) | 1.92040893 |
| 187 | regulation of beta-amyloid formation (GO:1902003) | 1.92021967 |
| 188 | macrophage activation involved in immune response (GO:0002281) | 1.91935331 |
| 189 | layer formation in cerebral cortex (GO:0021819) | 1.91116711 |
| 190 | glycerophospholipid catabolic process (GO:0046475) | 1.91053928 |
| 191 | growth hormone receptor signaling pathway (GO:0060396) | 1.90626907 |
| 192 | synaptic vesicle exocytosis (GO:0016079) | 1.89976023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.87959405 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.99542848 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.70266057 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63132291 |
| 5 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.48595827 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46443240 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.41400673 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.39448900 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19220192 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08209797 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07783126 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07609531 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06344584 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.00338042 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.99202369 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 1.96660653 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90188294 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88979756 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88776776 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87124622 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.81920981 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79927485 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78603579 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75538984 |
| 25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.74829461 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.73889796 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70815698 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68055472 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67222651 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67071436 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67071436 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62822109 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.62698116 |
| 34 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62599681 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61186427 |
| 36 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60725842 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58603385 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57908985 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57236062 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56647418 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.56514021 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.55016061 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.54658352 |
| 44 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.54510052 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53527964 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.53250876 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52826322 |
| 48 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47639582 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47456623 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45913583 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45753272 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45099869 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45014591 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44207003 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42695460 |
| 56 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.41981729 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41572568 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40671201 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.39571545 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39256643 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37232981 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36393437 |
| 63 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36140609 |
| 64 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35442313 |
| 65 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35442313 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35330619 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35189899 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.35170396 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34573304 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32833671 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31831927 |
| 72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31464979 |
| 73 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.29734816 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29263399 |
| 75 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29174419 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28068329 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27863294 |
| 78 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27261409 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26608657 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26423012 |
| 81 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26070644 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25655233 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25544729 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23887056 |
| 85 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23825076 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.23096104 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22652506 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22471503 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20723919 |
| 90 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19932441 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19674047 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.19416117 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19368025 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19246515 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17715378 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16707714 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16127968 |
| 98 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15319216 |
| 99 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14431359 |
| 100 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14334897 |
| 101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14147548 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13942880 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12538996 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11445987 |
| 105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.11133928 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10207383 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09707886 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09655827 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09385194 |
| 110 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.09202864 |
| 111 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.08827952 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08705114 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08506227 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08440196 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08242256 |
| 116 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.07557745 |
| 117 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07407816 |
| 118 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06477609 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04938948 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04895334 |
| 121 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.04358288 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03386980 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03247544 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02739027 |
| 125 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02136119 |
| 126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02044633 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01992142 |
| 128 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01958598 |
| 129 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01618480 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01227740 |
| 131 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01138843 |
| 132 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00873087 |
| 133 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00873087 |
| 134 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00673440 |
| 135 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00412813 |
| 136 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99279370 |
| 137 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99147830 |
| 138 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98561847 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97709434 |
| 140 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97614869 |
| 141 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97572299 |
| 142 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97221311 |
| 143 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97037169 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96281540 |
| 145 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95870990 |
| 146 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95735527 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95357515 |
| 148 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93942752 |
| 149 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.93199515 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93062955 |
| 151 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92639907 |
| 152 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92275693 |
| 153 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91391449 |
| 154 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91341318 |
| 155 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91294233 |
| 156 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91224010 |
| 157 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90712761 |
| 158 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90525786 |
| 159 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90402123 |
| 160 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89853945 |
| 161 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89515840 |
| 162 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88999023 |
| 163 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86905774 |
| 164 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85466503 |
| 165 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.85436602 |
| 166 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85294626 |
| 167 | AR_19668381_ChIP-Seq_PC3_Human | 0.84858640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.43450169 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.15866639 |
| 3 | MP0003724_increased_susceptibility_to | 3.95954787 |
| 4 | MP0000920_abnormal_myelination | 3.63235056 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.61403455 |
| 6 | MP0008260_abnormal_autophagy | 3.48754844 |
| 7 | MP0003690_abnormal_glial_cell | 2.93326392 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.72508481 |
| 9 | MP0001800_abnormal_humoral_immune | 2.63949953 |
| 10 | MP0005671_abnormal_response_to | 2.57317908 |
| 11 | MP0005171_absent_coat_pigmentation | 2.55482004 |
| 12 | MP0003436_decreased_susceptibility_to | 2.53090840 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.52529239 |
| 14 | MP0004270_analgesia | 2.47559720 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.47534334 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.45577287 |
| 17 | MP0000685_abnormal_immune_system | 2.44220882 |
| 18 | MP0003303_peritoneal_inflammation | 2.35038678 |
| 19 | MP0002009_preneoplasia | 2.32771477 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.27440363 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.27220080 |
| 22 | MP0002723_abnormal_immune_serum | 2.24025621 |
| 23 | MP0004043_abnormal_pH_regulation | 2.22807325 |
| 24 | MP0008057_abnormal_DNA_replication | 2.22056893 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.20802321 |
| 26 | MP0001819_abnormal_immune_cell | 2.18174046 |
| 27 | MP0005025_abnormal_response_to | 2.11120563 |
| 28 | MP0009785_altered_susceptibility_to | 2.10776693 |
| 29 | MP0004484_altered_response_of | 2.09897279 |
| 30 | MP0010678_abnormal_skin_adnexa | 2.08436651 |
| 31 | MP0005275_abnormal_skin_tensile | 2.03494655 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 2.02488741 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.98785474 |
| 34 | MP0003880_abnormal_central_pattern | 1.97066111 |
| 35 | MP0003045_fibrosis | 1.91371647 |
| 36 | MP0000427_abnormal_hair_cycle | 1.90419733 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.89918789 |
| 38 | MP0003329_amyloid_beta_deposits | 1.88351496 |
| 39 | MP0002398_abnormal_bone_marrow | 1.87587424 |
| 40 | MP0002064_seizures | 1.87258911 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.86513013 |
| 42 | MP0003091_abnormal_cell_migration | 1.84879326 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.83851711 |
| 44 | MP0004885_abnormal_endolymph | 1.83090398 |
| 45 | MP0003634_abnormal_glial_cell | 1.82246697 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.81809849 |
| 47 | MP0006054_spinal_hemorrhage | 1.78080458 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.75504168 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.71399324 |
| 50 | MP0000716_abnormal_immune_system | 1.71292385 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.68077679 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.67618594 |
| 53 | MP0003075_altered_response_to | 1.65997151 |
| 54 | MP0009745_abnormal_behavioral_response | 1.65882536 |
| 55 | MP0004883_abnormal_blood_vessel | 1.63473427 |
| 56 | MP0000604_amyloidosis | 1.62947446 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.57271233 |
| 58 | MP0009046_muscle_twitch | 1.56587802 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.56270600 |
| 60 | MP0002722_abnormal_immune_system | 1.55235689 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.55089812 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.55066271 |
| 63 | MP0002405_respiratory_system_inflammati | 1.53596848 |
| 64 | MP0001958_emphysema | 1.52436713 |
| 65 | MP0004381_abnormal_hair_follicle | 1.49065476 |
| 66 | MP0005310_abnormal_salivary_gland | 1.49061377 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.47928358 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.47903740 |
| 69 | MP0003828_pulmonary_edema | 1.47389865 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 1.45176310 |
| 71 | MP0002006_tumorigenesis | 1.42605744 |
| 72 | MP0001486_abnormal_startle_reflex | 1.42588692 |
| 73 | MP0003633_abnormal_nervous_system | 1.42418783 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.41153600 |
| 75 | MP0003632_abnormal_nervous_system | 1.40162916 |
| 76 | MP0002272_abnormal_nervous_system | 1.38649808 |
| 77 | MP0001851_eye_inflammation | 1.37579047 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.35064487 |
| 79 | MP0000383_abnormal_hair_follicle | 1.34928269 |
| 80 | MP0004272_abnormal_basement_membrane | 1.33635892 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.32618528 |
| 82 | MP0003787_abnormal_imprinting | 1.31802910 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.31265053 |
| 84 | MP0002429_abnormal_blood_cell | 1.31187376 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.30170553 |
| 86 | MP0003631_nervous_system_phenotype | 1.25988668 |
| 87 | MP0008569_lethality_at_weaning | 1.25474088 |
| 88 | MP0004510_myositis | 1.25359017 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 1.21994036 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.20335422 |
| 91 | MP0001177_atelectasis | 1.18619019 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.17532670 |
| 93 | MP0004858_abnormal_nervous_system | 1.15925481 |
| 94 | MP0005164_abnormal_response_to | 1.14748823 |
| 95 | MP0003566_abnormal_cell_adhesion | 1.13643064 |
| 96 | MP0000778_abnormal_nervous_system | 1.10878508 |
| 97 | MP0009764_decreased_sensitivity_to | 1.10336618 |
| 98 | MP0002572_abnormal_emotion/affect_behav | 1.10292809 |
| 99 | MP0003866_abnormal_defecation | 1.10198173 |
| 100 | MP0001986_abnormal_taste_sensitivity | 1.07330622 |
| 101 | MP0006082_CNS_inflammation | 1.06104346 |
| 102 | MP0002090_abnormal_vision | 1.05720480 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 1.04980270 |
| 104 | MP0005451_abnormal_body_composition | 1.04821875 |
| 105 | MP0000613_abnormal_salivary_gland | 1.04268015 |
| 106 | MP0002998_abnormal_bone_remodeling | 1.03711970 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 1.01529043 |
| 108 | MP0002133_abnormal_respiratory_system | 1.00297441 |
| 109 | MP0005388_respiratory_system_phenotype | 1.00297441 |
| 110 | MP0005409_darkened_coat_color | 0.99352717 |
| 111 | MP0005503_abnormal_tendon_morphology | 0.99266894 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.96823930 |
| 113 | MP0002419_abnormal_innate_immunity | 0.96746327 |
| 114 | MP0000733_abnormal_muscle_development | 0.91664972 |
| 115 | MP0001440_abnormal_grooming_behavior | 0.91446174 |
| 116 | MP0001501_abnormal_sleep_pattern | 0.90851137 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.90559477 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.90559477 |
| 119 | MP0000955_abnormal_spinal_cord | 0.90224020 |
| 120 | MP0004947_skin_inflammation | 0.89314685 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.87260225 |
| 122 | MP0008469_abnormal_protein_level | 0.86365028 |
| 123 | MP0004742_abnormal_vestibular_system | 0.85307117 |
| 124 | MP0000371_diluted_coat_color | 0.84309721 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.83689606 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.82393260 |
| 127 | MP0005166_decreased_susceptibility_to | 0.80723285 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.80637423 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.79042242 |
| 130 | MP0002060_abnormal_skin_morphology | 0.78877213 |
| 131 | MP0003795_abnormal_bone_structure | 0.78691811 |
| 132 | MP0002168_other_aberrant_phenotype | 0.78267038 |
| 133 | MP0005408_hypopigmentation | 0.76970997 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.76946750 |
| 135 | MP0001970_abnormal_pain_threshold | 0.75847371 |
| 136 | MP0004811_abnormal_neuron_physiology | 0.75706370 |
| 137 | MP0002933_joint_inflammation | 0.75190434 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.75149383 |
| 139 | MP0002229_neurodegeneration | 0.74212811 |
| 140 | MP0002882_abnormal_neuron_morphology | 0.73870955 |
| 141 | MP0010307_abnormal_tumor_latency | 0.73143880 |
| 142 | MP0002734_abnormal_mechanical_nocicepti | 0.72308134 |
| 143 | MP0009763_increased_sensitivity_to | 0.72262899 |
| 144 | MP0005076_abnormal_cell_differentiation | 0.71735924 |
| 145 | MP0000858_altered_metastatic_potential | 0.71298646 |
| 146 | MP0001790_abnormal_immune_system | 0.71288103 |
| 147 | MP0005387_immune_system_phenotype | 0.71288103 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71084392 |
| 149 | MP0001849_ear_inflammation | 0.70480201 |
| 150 | MP0003195_calcinosis | 0.69750809 |
| 151 | MP0005000_abnormal_immune_tolerance | 0.69616885 |
| 152 | MP0010771_integument_phenotype | 0.68592423 |
| 153 | MP0009278_abnormal_bone_marrow | 0.68538718 |
| 154 | MP0002796_impaired_skin_barrier | 0.68113711 |
| 155 | MP0004134_abnormal_chest_morphology | 0.67923116 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.66961614 |
| 157 | MP0003448_altered_tumor_morphology | 0.66878688 |
| 158 | MP0001915_intracranial_hemorrhage | 0.66783673 |
| 159 | MP0002877_abnormal_melanocyte_morpholog | 0.66471426 |
| 160 | MP0002896_abnormal_bone_mineralization | 0.65485324 |
| 161 | MP0004130_abnormal_muscle_cell | 0.64840020 |
| 162 | MP0002066_abnormal_motor_capabilities/c | 0.64564883 |
| 163 | MP0001873_stomach_inflammation | 0.64463959 |
| 164 | MP0000462_abnormal_digestive_system | 0.64410833 |
| 165 | MP0008874_decreased_physiological_sensi | 0.63682794 |
| 166 | MP0000747_muscle_weakness | 0.62995600 |
| 167 | MP0002108_abnormal_muscle_morphology | 0.62851069 |
| 168 | MP0003943_abnormal_hepatobiliary_system | 0.60474343 |
| 169 | MP0000647_abnormal_sebaceous_gland | 0.60460104 |
| 170 | MP0001765_abnormal_ion_homeostasis | 0.60177486 |
| 171 | MP0008877_abnormal_DNA_methylation | 0.60015518 |
| 172 | MP0003252_abnormal_bile_duct | 0.57410941 |
| 173 | MP0000249_abnormal_blood_vessel | 0.56869161 |
| 174 | MP0009765_abnormal_xenobiotic_induced | 0.56287123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.93684299 |
| 2 | T lymphocytopenia (HP:0005403) | 4.11212825 |
| 3 | Abnormality of T cell number (HP:0011839) | 3.88768787 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.82215289 |
| 5 | Long nose (HP:0003189) | 3.70261522 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.68563650 |
| 7 | Optic neuritis (HP:0100653) | 3.62894544 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.62894544 |
| 9 | Myositis (HP:0100614) | 3.45846928 |
| 10 | Orchitis (HP:0100796) | 3.41334967 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34059776 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34059776 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31957112 |
| 14 | Recurrent skin infections (HP:0001581) | 3.31692907 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.31226311 |
| 16 | Stomatitis (HP:0010280) | 3.24606448 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.16236561 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.10921939 |
| 19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.10326619 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.10326619 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.10093592 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.02718946 |
| 23 | Shallow orbits (HP:0000586) | 2.93515865 |
| 24 | Onion bulb formation (HP:0003383) | 2.91029242 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91012211 |
| 26 | Arterial tortuosity (HP:0005116) | 2.88725812 |
| 27 | Conical tooth (HP:0000698) | 2.87161181 |
| 28 | Intention tremor (HP:0002080) | 2.86763826 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.85589599 |
| 30 | Meningitis (HP:0001287) | 2.84117236 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.81522072 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.81322688 |
| 33 | Broad metatarsal (HP:0001783) | 2.81289440 |
| 34 | Sensory axonal neuropathy (HP:0003390) | 2.76120928 |
| 35 | Encephalitis (HP:0002383) | 2.75293991 |
| 36 | Recurrent viral infections (HP:0004429) | 2.74744755 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.74214053 |
| 38 | Gingival bleeding (HP:0000225) | 2.69165854 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65243831 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.64654725 |
| 41 | Neoplasm of the oral cavity (HP:0100649) | 2.63492979 |
| 42 | Abnormality of T cells (HP:0002843) | 2.62779151 |
| 43 | Dysmetria (HP:0001310) | 2.62762441 |
| 44 | Vascular tortuosity (HP:0004948) | 2.62056997 |
| 45 | Progressive inability to walk (HP:0002505) | 2.60688726 |
| 46 | Buphthalmos (HP:0000557) | 2.57321446 |
| 47 | Arterial thrombosis (HP:0004420) | 2.56852705 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.55324748 |
| 49 | Acute lymphatic leukemia (HP:0006721) | 2.52887579 |
| 50 | Termporal pattern (HP:0011008) | 2.52195325 |
| 51 | Insidious onset (HP:0003587) | 2.52195325 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.51715001 |
| 53 | Broad-based gait (HP:0002136) | 2.50405385 |
| 54 | Aortic dissection (HP:0002647) | 2.49094097 |
| 55 | Gingivitis (HP:0000230) | 2.48996361 |
| 56 | Chest pain (HP:0100749) | 2.48851262 |
| 57 | Subacute progressive viral hepatitis (HP:0006572) | 2.48529285 |
| 58 | Leukocytosis (HP:0001974) | 2.47421219 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.46240417 |
| 60 | Vasculitis (HP:0002633) | 2.46030462 |
| 61 | Thyroiditis (HP:0100646) | 2.43511973 |
| 62 | Myokymia (HP:0002411) | 2.41250567 |
| 63 | Action tremor (HP:0002345) | 2.39277890 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.39183934 |
| 65 | Acute myeloid leukemia (HP:0004808) | 2.38879631 |
| 66 | Viral hepatitis (HP:0006562) | 2.38747766 |
| 67 | Stomach cancer (HP:0012126) | 2.37280554 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.37113361 |
| 69 | Periodontitis (HP:0000704) | 2.34024603 |
| 70 | Hemoptysis (HP:0002105) | 2.33777757 |
| 71 | Hyperventilation (HP:0002883) | 2.32300573 |
| 72 | Urticaria (HP:0001025) | 2.29401761 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.28303331 |
| 74 | Amyotrophic lateral sclerosis (HP:0007354) | 2.28220568 |
| 75 | Axonal loss (HP:0003447) | 2.27095565 |
| 76 | Hematochezia (HP:0002573) | 2.26513662 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.24215354 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24215354 |
| 79 | Aqueductal stenosis (HP:0002410) | 2.22387422 |
| 80 | Focal motor seizures (HP:0011153) | 2.22117875 |
| 81 | Abnormality of eosinophils (HP:0001879) | 2.20902024 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.20061920 |
| 83 | Focal seizures (HP:0007359) | 2.19957933 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19506107 |
| 85 | Spastic gait (HP:0002064) | 2.19465893 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.19388721 |
| 87 | Eosinophilia (HP:0001880) | 2.18894244 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18635414 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.18040517 |
| 90 | Turricephaly (HP:0000262) | 2.17740757 |
| 91 | Abnormality of B cell number (HP:0010975) | 2.16614596 |
| 92 | Hypoplasia of the iris (HP:0007676) | 2.16321496 |
| 93 | Epistaxis (HP:0000421) | 2.15841576 |
| 94 | Obstructive lung disease (HP:0006536) | 2.15488090 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15488090 |
| 96 | Absent frontal sinuses (HP:0002688) | 2.15033352 |
| 97 | Peripheral hypomyelination (HP:0007182) | 2.14790761 |
| 98 | Scanning speech (HP:0002168) | 2.14183741 |
| 99 | Recurrent bronchitis (HP:0002837) | 2.13265916 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.12562800 |
| 101 | Osteomyelitis (HP:0002754) | 2.11688388 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.09440732 |
| 103 | Granulocytopenia (HP:0001913) | 2.07266122 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.06977849 |
| 105 | Autoimmune hemolytic anemia (HP:0001890) | 2.06577760 |
| 106 | Coronal craniosynostosis (HP:0004440) | 2.06315233 |
| 107 | Ulnar bowing (HP:0003031) | 2.06298273 |
| 108 | Diplopia (HP:0000651) | 2.03343876 |
| 109 | Abnormality of binocular vision (HP:0011514) | 2.03343876 |
| 110 | Papilledema (HP:0001085) | 2.02391425 |
| 111 | Mitral valve prolapse (HP:0001634) | 2.02204969 |
| 112 | Pustule (HP:0200039) | 2.01040106 |
| 113 | Macroorchidism (HP:0000053) | 2.00368264 |
| 114 | Heterotopia (HP:0002282) | 2.00266602 |
| 115 | Thickened helices (HP:0000391) | 1.99772110 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.99061069 |
| 117 | Thick nail (HP:0001805) | 1.97996168 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97821068 |
| 119 | Oligodontia (HP:0000677) | 1.97749219 |
| 120 | Aortic aneurysm (HP:0004942) | 1.97428168 |
| 121 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97391256 |
| 122 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97391256 |
| 123 | Aplasia involving bones of the extremities (HP:0009825) | 1.97391256 |
| 124 | Spondylolisthesis (HP:0003302) | 1.96449515 |
| 125 | Colitis (HP:0002583) | 1.96041975 |
| 126 | Basal cell carcinoma (HP:0002671) | 1.95067741 |
| 127 | Metaphyseal dysplasia (HP:0100255) | 1.94980334 |
| 128 | Widely spaced teeth (HP:0000687) | 1.94160326 |
| 129 | Papillary thyroid carcinoma (HP:0002895) | 1.94141372 |
| 130 | Cellulitis (HP:0100658) | 1.94088709 |
| 131 | Megalencephaly (HP:0001355) | 1.89777371 |
| 132 | Anteriorly placed anus (HP:0001545) | 1.89713442 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.87381127 |
| 134 | Peritonitis (HP:0002586) | 1.86737148 |
| 135 | Agammaglobulinemia (HP:0004432) | 1.85832975 |
| 136 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84748491 |
| 137 | Pulmonary embolism (HP:0002204) | 1.84239733 |
| 138 | Hypoplasia of the thymus (HP:0000778) | 1.84090834 |
| 139 | Scapular winging (HP:0003691) | 1.83589493 |
| 140 | Disproportionate tall stature (HP:0001519) | 1.83320986 |
| 141 | B lymphocytopenia (HP:0010976) | 1.82914135 |
| 142 | Bulbous nose (HP:0000414) | 1.82674271 |
| 143 | Severe combined immunodeficiency (HP:0004430) | 1.81863236 |
| 144 | Lymphopenia (HP:0001888) | 1.81829354 |
| 145 | Fair hair (HP:0002286) | 1.81662784 |
| 146 | Atrophic scars (HP:0001075) | 1.81159754 |
| 147 | Amaurosis fugax (HP:0100576) | 1.80962134 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.80686636 |
| 149 | Infantile muscular hypotonia (HP:0008947) | 1.80327852 |
| 150 | Loss of speech (HP:0002371) | 1.79725300 |
| 151 | Abnormal platelet volume (HP:0011876) | 1.79691639 |
| 152 | Deep philtrum (HP:0002002) | 1.79497364 |
| 153 | Slender build (HP:0001533) | 1.79344305 |
| 154 | Ankle clonus (HP:0011448) | 1.78794367 |
| 155 | Recurrent abscess formation (HP:0002722) | 1.78525706 |
| 156 | Neonatal hypoglycemia (HP:0001998) | 1.78465001 |
| 157 | Clumsiness (HP:0002312) | 1.78315100 |
| 158 | Hyporeflexia of lower limbs (HP:0002600) | 1.77409593 |
| 159 | Abnormal auditory evoked potentials (HP:0006958) | 1.76818850 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.76465840 |
| 161 | Ankle contracture (HP:0006466) | 1.75725011 |
| 162 | Protrusio acetabuli (HP:0003179) | 1.75188165 |
| 163 | Microcytic anemia (HP:0001935) | 1.75108555 |
| 164 | Hammertoe (HP:0001765) | 1.75054159 |
| 165 | Premature skin wrinkling (HP:0100678) | 1.74478228 |
| 166 | Dysostosis multiplex (HP:0000943) | 1.74025096 |
| 167 | Abnormality of lateral ventricle (HP:0030047) | 1.73551072 |
| 168 | Arnold-Chiari malformation (HP:0002308) | 1.73174841 |
| 169 | Hemiplegia (HP:0002301) | 1.72993916 |
| 170 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.72865509 |
| 171 | Bronchomalacia (HP:0002780) | 1.72673150 |
| 172 | Alacrima (HP:0000522) | 1.71915859 |
| 173 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70810463 |
| 174 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70810463 |
| 175 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70810463 |
| 176 | Postural instability (HP:0002172) | 1.70240901 |
| 177 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69872769 |
| 178 | Large earlobe (HP:0009748) | 1.69222009 |
| 179 | Wormian bones (HP:0002645) | 1.68480898 |
| 180 | Bell-shaped thorax (HP:0001591) | 1.66569367 |
| 181 | Dysdiadochokinesis (HP:0002075) | 1.64900843 |
| 182 | Atonic seizures (HP:0010819) | 1.63660960 |
| 183 | Parakeratosis (HP:0001036) | 1.62706709 |
| 184 | Dilatation of the ascending aorta (HP:0005111) | 1.62240885 |
| 185 | Gaze-evoked nystagmus (HP:0000640) | 1.61162631 |
| 186 | Disinhibition (HP:0000734) | 1.60722111 |
| 187 | Follicular hyperkeratosis (HP:0007502) | 1.60671804 |
| 188 | Lower limb muscle weakness (HP:0007340) | 1.59671024 |
| 189 | Decreased motor nerve conduction velocity (HP:0003431) | 1.59535048 |
| 190 | Eczematoid dermatitis (HP:0000976) | 1.59067782 |
| 191 | Narrow palate (HP:0000189) | 1.57575472 |
| 192 | Distal upper limb amyotrophy (HP:0007149) | 1.56880332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.93826249 |
| 2 | STK39 | 3.02833445 |
| 3 | EPHA4 | 2.77129660 |
| 4 | EPHB1 | 2.65399618 |
| 5 | IRAK4 | 2.65092919 |
| 6 | CDC42BPA | 2.59603432 |
| 7 | BLK | 2.58930846 |
| 8 | FGFR2 | 2.44275069 |
| 9 | TYK2 | 2.20210127 |
| 10 | TEC | 2.07426501 |
| 11 | TXK | 2.06217379 |
| 12 | MAP3K13 | 2.01723541 |
| 13 | MAP4K1 | 1.96441100 |
| 14 | RIPK4 | 1.95512046 |
| 15 | WNK1 | 1.95089545 |
| 16 | CAMK1G | 1.95016122 |
| 17 | OXSR1 | 1.88254275 |
| 18 | MAP3K9 | 1.86534071 |
| 19 | FGR | 1.80941377 |
| 20 | NTRK1 | 1.80481852 |
| 21 | IKBKE | 1.78613609 |
| 22 | BTK | 1.76003112 |
| 23 | GRK6 | 1.74720326 |
| 24 | SGK2 | 1.72518436 |
| 25 | CAMK1D | 1.71847248 |
| 26 | PAK6 | 1.69756461 |
| 27 | KIT | 1.69380934 |
| 28 | KSR2 | 1.65796663 |
| 29 | BMPR2 | 1.65134636 |
| 30 | MET | 1.65102745 |
| 31 | PIK3CG | 1.64258699 |
| 32 | JAK3 | 1.62488188 |
| 33 | DMPK | 1.60259479 |
| 34 | NTRK3 | 1.57589144 |
| 35 | MAP2K3 | 1.57546330 |
| 36 | SYK | 1.56670669 |
| 37 | PRPF4B | 1.52277771 |
| 38 | RIPK1 | 1.51146091 |
| 39 | IRAK1 | 1.48961150 |
| 40 | TRPM7 | 1.46620772 |
| 41 | MAP3K2 | 1.41124024 |
| 42 | DDR2 | 1.38220435 |
| 43 | FES | 1.38207367 |
| 44 | BMX | 1.34767196 |
| 45 | YES1 | 1.31123986 |
| 46 | TTN | 1.27273638 |
| 47 | ZAP70 | 1.26951328 |
| 48 | MARK2 | 1.24301710 |
| 49 | JAK2 | 1.23273780 |
| 50 | PDGFRB | 1.22147067 |
| 51 | NLK | 1.21643277 |
| 52 | PRKCH | 1.21216018 |
| 53 | PKN1 | 1.21071109 |
| 54 | LYN | 1.19425933 |
| 55 | CDK3 | 1.15655963 |
| 56 | * LCK | 1.12939917 |
| 57 | LATS1 | 1.09155057 |
| 58 | CSNK1A1L | 1.07256545 |
| 59 | CAMK2B | 1.06472170 |
| 60 | TYRO3 | 1.06403090 |
| 61 | MAPKAPK5 | 1.05568072 |
| 62 | CLK1 | 1.02357790 |
| 63 | ROCK2 | 1.01496692 |
| 64 | JAK1 | 1.01134156 |
| 65 | BCR | 1.00979831 |
| 66 | TNK2 | 1.00215666 |
| 67 | CDK5 | 0.99106798 |
| 68 | PDGFRA | 0.98496909 |
| 69 | CSNK1G2 | 0.98460527 |
| 70 | DAPK2 | 0.98341331 |
| 71 | RET | 0.96268989 |
| 72 | EPHA3 | 0.93883999 |
| 73 | FYN | 0.91626466 |
| 74 | CSF1R | 0.90853969 |
| 75 | CAMKK1 | 0.89536993 |
| 76 | CSK | 0.89355027 |
| 77 | PRKCQ | 0.88293978 |
| 78 | PDPK1 | 0.88224289 |
| 79 | STK38 | 0.88071680 |
| 80 | TNIK | 0.87685352 |
| 81 | SCYL2 | 0.87465755 |
| 82 | MAP3K14 | 0.85766614 |
| 83 | NEK6 | 0.85715771 |
| 84 | RPS6KA4 | 0.85701247 |
| 85 | MAP3K7 | 0.85544967 |
| 86 | PRKD1 | 0.84685965 |
| 87 | PTK6 | 0.83399944 |
| 88 | ITK | 0.80729574 |
| 89 | ICK | 0.80701463 |
| 90 | MAP3K10 | 0.80243517 |
| 91 | PTK2B | 0.79758607 |
| 92 | STK11 | 0.77587463 |
| 93 | TGFBR2 | 0.77350078 |
| 94 | PDK1 | 0.77292042 |
| 95 | SGK494 | 0.75825807 |
| 96 | SGK223 | 0.75825807 |
| 97 | MOS | 0.75494289 |
| 98 | STK10 | 0.73902232 |
| 99 | MATK | 0.73766011 |
| 100 | ALK | 0.73647402 |
| 101 | HIPK2 | 0.73539521 |
| 102 | SIK2 | 0.73463328 |
| 103 | PAK3 | 0.73354437 |
| 104 | * HCK | 0.73116804 |
| 105 | IKBKB | 0.71551535 |
| 106 | PTK2 | 0.70579464 |
| 107 | ACVR1B | 0.69808087 |
| 108 | MARK3 | 0.69212420 |
| 109 | IRAK2 | 0.68956446 |
| 110 | FER | 0.68766345 |
| 111 | FGFR1 | 0.68366302 |
| 112 | NEK9 | 0.68326100 |
| 113 | PLK2 | 0.68257829 |
| 114 | CAMK2D | 0.65274898 |
| 115 | BRSK2 | 0.63357736 |
| 116 | INSR | 0.62713972 |
| 117 | SGK1 | 0.62275378 |
| 118 | FGFR3 | 0.61585938 |
| 119 | TBK1 | 0.61201344 |
| 120 | MELK | 0.59793255 |
| 121 | STK4 | 0.59382540 |
| 122 | PRKD3 | 0.59224625 |
| 123 | FLT3 | 0.58726420 |
| 124 | NTRK2 | 0.56458114 |
| 125 | MAP3K3 | 0.56257786 |
| 126 | PAK2 | 0.54522854 |
| 127 | WNK4 | 0.54413970 |
| 128 | PRKD2 | 0.53354469 |
| 129 | PRKCE | 0.53333391 |
| 130 | PBK | 0.53187205 |
| 131 | UHMK1 | 0.51342721 |
| 132 | ADRBK1 | 0.50795005 |
| 133 | SRC | 0.49906295 |
| 134 | FRK | 0.49199339 |
| 135 | STK3 | 0.48796870 |
| 136 | SGK3 | 0.46662813 |
| 137 | EIF2AK3 | 0.46540027 |
| 138 | CAMK2A | 0.46241353 |
| 139 | MAPK10 | 0.46139809 |
| 140 | CAMKK2 | 0.45572090 |
| 141 | EGFR | 0.45116672 |
| 142 | BRD4 | 0.44953115 |
| 143 | CAMK4 | 0.44650025 |
| 144 | NUAK1 | 0.44418762 |
| 145 | CSNK1G3 | 0.44299791 |
| 146 | CDK14 | 0.44171117 |
| 147 | AKT3 | 0.43928968 |
| 148 | KSR1 | 0.43814393 |
| 149 | SIK1 | 0.43485689 |
| 150 | MAP3K6 | 0.43245541 |
| 151 | MAP3K1 | 0.43065921 |
| 152 | PIM1 | 0.42509617 |
| 153 | PRKAA2 | 0.40656569 |
| 154 | GRK5 | 0.40276813 |
| 155 | DYRK3 | 0.35075060 |
| 156 | * ABL1 | 0.32111356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00958895 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 1.97713592 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89121155 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.84961558 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82675308 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81849584 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71874471 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.67641764 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65165333 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.60849676 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57093601 |
| 12 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53000092 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51937741 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51634004 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50908828 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50577039 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50030518 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.48652415 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47588863 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.47254431 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46839476 |
| 22 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.46616005 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42020103 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37749598 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.37403152 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.34616565 |
| 27 | Axon guidance_Homo sapiens_hsa04360 | 1.28912352 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28133795 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27752042 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27392717 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.26728477 |
| 32 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.26424473 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24696223 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.24395392 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24277672 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.23111907 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.21533570 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18643771 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17800591 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17761833 |
| 41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17106888 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16578234 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15725250 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.13543600 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12763241 |
| 46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12677770 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.12257297 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11219746 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10853624 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.10475933 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09773407 |
| 52 | * Endocytosis_Homo sapiens_hsa04144 | 1.09222373 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08251258 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.07470251 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06336580 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05286428 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05211917 |
| 58 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05199867 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.05162477 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.04988093 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.04977151 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.04616685 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03562194 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03113938 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 1.02885834 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 1.02402925 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02124737 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01258863 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00994394 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00780331 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00061066 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96066158 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94314488 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94086874 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93701487 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.93619684 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92848160 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.92684225 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92601911 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92378037 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91321112 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91072361 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90789241 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.89241043 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88825538 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.88746828 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86931836 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86310417 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.85266330 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.82710286 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82446737 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81846501 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81421200 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.81277124 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81131995 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.80981893 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80643716 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80045116 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79571162 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79109915 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78096077 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77808066 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.77751955 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77127613 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75849747 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75401397 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75383166 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74349266 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74002254 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73808698 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73547555 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72815723 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72340886 |
| 114 | Insulin secretion_Homo sapiens_hsa04911 | 0.72277524 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71692551 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69717938 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69646454 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.68438363 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68147402 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67787726 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67352312 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.65773730 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.65540465 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65270132 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64872618 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64836231 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.64830871 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64513197 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64483548 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63453492 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63153522 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62944100 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.62553422 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62416952 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.62080790 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61996780 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61824998 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61436889 |
| 139 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60044925 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59482791 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.56636847 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55858631 |
| 143 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52897178 |
| 144 | Apoptosis_Homo sapiens_hsa04210 | 0.52539454 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50731824 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.49703538 |
| 147 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48991765 |
| 148 | Taste transduction_Homo sapiens_hsa04742 | 0.45533978 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45003628 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42883297 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39783034 |
| 152 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39732973 |

